Charting the landscape for EGFR-positive NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

• Evaluate novel data in molecular testing for EGFR+ NSCLC
• Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

Faculty:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)
• Reinhard Büttner (Germany)
• Sanjay Popat (UK)

Claim your CPD credits

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1 credit for this activity.

Please make a note of the below information to claim your points.

Name of activity: Janssen Oncology Medical Education (OME) webinar four: Charting the landscape for EGFR+ NSCLC

Certificate number: A029777

Date of activity: October 2021

Provider: Sciterion 013096